Investing with options: Meta Platforms, Inc. earnings

Investing with options: Meta Platforms, Inc. earnings

Options 10 minutes to read
Koen Hoorelbeke

Investment and Options Strategist

Summary:  In the wake of Meta's upcoming Q3 earnings release, various options strategies offer intriguing avenues for investors with different market outlooks. From buying long-dated call options for bullish leverage to selling in-the-money puts for effective stock acquisition at a discount, and writing covered calls for additional income, options provide flexibility and strategic depth. Each approach comes with its own risk-reward profile, making options an invaluable tool for navigating earnings season and beyond.


Investing with options - Meta Platforms, Inc. earnings

Meta Platforms, Inc., formerly known as Facebook Inc, is expected to announce its third-quarter earnings on Wednesday, October 25th, after market hours. Analysts have projected an EPS of $3.57 and revenue of $33.43 billion. Despite facing competitive pressure and a slowing advertising revenue growth, Meta is still expected to deliver strong numbers. Regardless of the outcome, options offer versatile strategies for both bullish and bearish investors.
Important note: the strategies and examples provided in this article are purely for educational purposes. They are intended to assist in shaping your thought process and should not be replicated or implemented without careful consideration. Every investor or trader must conduct their own due diligence and take into account their unique financial situation, risk tolerance, and investment objectives before making any decisions. Remember, investing in the stock market carries risk, and it's crucial to make informed decisions.
 

Strategies

1. Bullish outlook - buying call options:

Considering Meta's recent pullback, a long call option can capitalize on potential upside.

  • Execution: BuyToOpen 1 20-Sep-2024 Call 250 @ $94.90 (Delta: 0.81).
  • Premium: Per share: $94.90 (debit)
  • Premium and risk:
    • Premium cost: $94.90 x 100 (per contract) = $9,490
    • Max risk: $9,490 (if Meta remains below 250 at expiry)
    • Max reward: Significant (gains rise as Meta's stock price rises)
  • Breakeven point: $250 (strike) + $94.90 (premium) = $344.90
  • Rationale: Opting for a longer expiration minimizes the impact of time decay (or "theta decay").
  • Stock vs Options Comparison: With the same amount of $9,490, you could buy approximately 30 shares of Meta at its current price of $316.30. If Meta's stock price increases by $1:
    • With the stock, you would make $30 (30 shares x $1).
    • With the call option, your profit would be calculated as follows: 100 (contract multiplier) x $1 (price increase) x 0.81 (Delta) = $81.
 

2. Bullish outlook - selling ITM put options:

 
Selling in-the-money (ITM) put options can be another method to acquire Meta shares at a discount.
  • Execution: SellToOpen 1 27-Oct-2023 Put 327.50 @ $19.55 (Delta: -0.22).
  • Premium: Per share: $19.55 (credit)
  • Premium and risk:
    • Premium earned: $19.55 x 100 (per contract) = $1,955
    • Max risk: Significant (if Meta stock falls significantly)
  • Breakeven point: $327.50 (strike) - $19.55 (premium) = $307.95
  • Rationale: A shorter expiration allows for quicker premium capture, but the risk is owning the stock if it drops below the strike price.
  • Stock vs Options Comparison:
    • The current price of Meta is $316.30. By selling this ITM put option, you get to buy Meta at an effective price of $307.95 per share, thanks to the premium received.
    • Discount in Effective Price: $(316.30 - 307.95) = $8.35 per share
    • Percentage Discount: ($8.35 / $316.30) x 100 = approximately 2.64%
 

3. Bearish outlook - buying put options:

If you believe Meta's stock is set for a decline, a long put option can be suitable.
  • Execution: BuyToOpen 1 20-Sep-2024 Put 380 @ $80.55 (Delta: -0.62).
  • Premium: Per share: $80.55 (debit)
  • Premium and risk:
    • Premium cost: $80.55 x 100 (per contract) = $8,055
    • Max risk: $8,055 (if Meta remains above 380 at expiry)
    • Max reward: Significant (gains rise as Meta's stock price falls)
  • Breakeven point: $380 (strike) - $80.55 (premium) = $299.45
  • Rationale: A longer expiration again helps mitigate the effects of time decay.
  • Stock vs Options Comparison:
    • If Meta’s stock price decreases by $1:
    • With the stock, you would lose $1 per share if you are holding the stock.
    • With the bought put option, your profit would be: 100 x $1 x 0.62 (delta) = $62
 

4. Neutral/bullish outlook - writing covered calls:

If you already own Meta shares, covered calls can generate additional income.
  • Execution: SellToOpen 1 03-Nov-2023 Call 350 @ $3.40 (Delta: 0.19).
  • Premium: Per share: $3.40 (credit)
  • Premium and risk:
    • Premium earned: $3.40 x 100 (per contract) = $340
    • Max risk: Limited to stock ownership
  • Breakeven point: Varies based on stock cost basis
  • Yield for covered call: 11-day yield: 1.07%
    • Annualized yield: 35.56%
  • Rationale: Writing covered calls provides income but caps upside potential. The strategy is effective if you expect the stock to trade sideways or slightly up in the short term.
  • Stock vs Options Comparison:
    • With the stock, you receive no income unless you sell the shares or they pay dividends.
    • With a covered call, you receive immediate income and potentially have the stock called away at $350, which might or might not be beneficial depending on your outlook.
 

Conclusion

When it comes to investing in options around Meta's earnings, each strategy comes with its unique set of rewards and risks. The key is aligning your strategy with your market outlook and risk tolerance.
 
The comparisons between buying stock and using options reveal interesting facets:
 
  • Buying calls: The leverage effect of a call option allows you to control the same amount of stock with less capital. A $1 increase in Meta's stock results in an $81 gain with a call, compared to a $30 gain by holding 30 shares of the stock.
  • Selling ITM puts: This strategy could allow you to acquire Meta at a discounted rate compared to buying shares directly. The effective purchase price would be the strike minus the premium received, which can be calculated as a percentage discount against the current stock price.
  • Buying puts: Options offer a leveraged way to bet against the stock with a defined risk, which can be particularly useful in volatile times.
  • Writing covered calls: This strategy provides additional income and an annualized yield of 35.44%, which you can't get by just holding the stock.
Each option strategy can serve a purpose depending on your viewpoint on the stock and market conditions, making options a flexible tool for various investment goals.

Options are complex, high-risk products and require knowledge, investment experience and, in many applications, high risk acceptance. We recommend that before you invest in options, you inform yourself well about the operation and risks. In Saxo Bank's Terms of Use you will find more information on this in the Important Information Options, Futures, Margin and Deficit Procedure. You can also consult the Essential Information Document of the option you want to invest in on Saxo Bank's website.

Quarterly Outlook

01 /

  • Macro Outlook: The US rate cut cycle has begun

    Quarterly Outlook

    Macro Outlook: The US rate cut cycle has begun

    Peter Garnry

    Chief Investment Strategist

    The Fed started the US rate cut cycle in Q3 and in this macro outlook we will explore how the rate c...
  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

  • Equity Outlook: Will lower rates lift all boats in equities?

    Quarterly Outlook

    Equity Outlook: Will lower rates lift all boats in equities?

    Peter Garnry

    Chief Investment Strategist

    After a period of historically high equity index concentration driven by the 'Magnificent Seven' sto...
  • FX Outlook: USD in limbo amid political and policy jitters

    Quarterly Outlook

    FX Outlook: USD in limbo amid political and policy jitters

    Charu Chanana

    Chief Investment Strategist

    As we enter the final quarter of 2024, currency markets are set for heightened turbulence due to US ...
  • Commodity Outlook: Gold and silver continue to shine bright

    Quarterly Outlook

    Commodity Outlook: Gold and silver continue to shine bright

    Ole Hansen

    Head of Commodity Strategy

  • FX: Risk-on currencies to surge against havens

    Quarterly Outlook

    FX: Risk-on currencies to surge against havens

    Charu Chanana

    Chief Investment Strategist

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperfo...
  • Equities: Are we blowing bubbles again

    Quarterly Outlook

    Equities: Are we blowing bubbles again

    Peter Garnry

    Chief Investment Strategist

    Explore key trends and opportunities in European equities and electrification theme as market dynami...
  • Macro: Sandcastle economics

    Quarterly Outlook

    Macro: Sandcastle economics

    Peter Garnry

    Chief Investment Strategist

    Explore the "two-lane economy," European equities, energy commodities, and the impact of US fiscal p...
  • Bonds: What to do until inflation stabilises

    Quarterly Outlook

    Bonds: What to do until inflation stabilises

    Althea Spinozzi

    Head of Fixed Income Strategy

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain ...
  • Commodities: Energy and grains in focus as metals pause

    Quarterly Outlook

    Commodities: Energy and grains in focus as metals pause

    Ole Hansen

    Head of Commodity Strategy

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities i...
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.